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BACKGROUND: The prevalence of chronic disease and do-not-intubate status increases with age.
Thus, we aimed to determine characteristics and outcomes associated with noninvasive ventilation
(NIV) use for acute respiratory failure (ARF) in different age groups. METHODS: A database
comprising prospective data collected on site on all adult patients with ARF requiring ventilatory
support from 8 acute care hospitals in Massachusetts was used. RESULTS: From a total of 1,225
ventilator starts, overall NIV utilization, success, and in-hospital mortality rates were 22, 54, and
18% in younger (18–44 y); 34, 65, and 13% in middle-aged (45–64 y); 49, 68, and 17% in elderly
(65–79 y); and 47, 76, and 24% in aged (>80 y) groups, respectively (P< .001, P .08, and P .11,
respectively). NIV use for cardiogenic pulmonary edema and subjects with a do-not-intubate order
increased significantly with advancing age (25, 57, 57, and 74% and 7, 12, 18, and 31%, respectively,
in the 4 age groups [P < .001 and P  .046, respectively]). For subjects receiving NIV with a
do-not-intubate order, success and in-hospital mortality rates were similar in different age groups
(P  .27 and P  .98, respectively). CONCLUSIONS: NIV use and a do-not-intubate status are
more frequent in subjects with ARF >65 y than in those <65 y, especially for subjects with car-
diogenic pulmonary edema. However, NIV success and mortality rates were similar between age
groups. (ClinicalTrials.gov registration NCT00458926.) Key words: noninvasive ventilation; acute respi-
ratory failure; elderly; aged; middle-aged. [Respir Care 2016;61(1):36–43. © 2016 Daedalus Enterprises]
Introduction
Based on the United States National In-patient Sample
database, the number of hospitalizations for acute respira-
tory failure (ARF), one of the most frequent reasons for
hospitalization,1 almost doubled between 2001 and 2009.2
The overall rate of mechanical ventilation remained steady
at approximately 50%, but noninvasive ventilation (NIV)
increased from 3.8 to 10.1%, whereas the use of invasive
mechanical ventilation fell from 48.5 to 42.1%. Older pa-
tients (85 y) more often received NIV than younger ones
(12.7% vs 7%),2 and were also more apt to have do-not-
intubate orders than younger ones.3 Considering that NIV
is frequently offered for management of ARF in patients
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with do-not-intubate orders as a ceiling of ventilator care
or palliative therapy,4-9 this also would be expected to
favor greater use of NIV in the elderly.
Most prior studies on NIV use in the elderly have been
retrospective or based on questionnaires or databases col-
lected on the basis of billing codes,2,3,10-13 limiting the
ability to identify clinical characteristics associated with
NIV use. Additionally, current data regarding NIV use in
the elderly has been derived mainly from hypercapnic sub-
jects treated in ICUs or intermediate care units,4,6,7 whereas
elderly and do-not-intubate patients are not uncommonly
treated on regular medical wards.5
In the present study, we used a database collected on
site at a group of acute care hospitals in Massachusetts
including all patients receiving ventilatory assistance for
ARF (hypercapnic/hypoxic) in any hospital location and
recorded multiple clinical and physiologic variables. Us-
ing this unique database, we sought to determine the uti-
lization rate of NIV as a percentage of all ventilator starts
for ARF in each age group and to confirm the hypothesis
that NIV is used more often in older age groups. We also
assessed subject characteristics and outcomes associated
with NIV use in different age groups.
Methods
Setting and Population
Our database was designed to study the impact of an
educational intervention on NIV utilization and its out-
comes for subjects with ARF in 8 hospitals previously
found to be low NIV utilizers at the time of a prior NIV
survey taken in Massachusetts and Rhode Island.12 Of the
hospitals, 3 were randomly designated as control, whereas
5 of them were educational intervention sites. The results
of the intervention study will be reported separately. The
institutional review boards of participating institutions ap-
proved the study (Tufts ID 7642) and waived the need for
patient consent because it was observational only.
The study was conducted at each institution during se-
quential 3-month data collection periods at baseline (be-
fore) between January 1, 2004, and August 3, 2007, and
after the intervention or control periods (after) between
August 25, 2005, and December 26, 2009. All subjects
receiving mechanical ventilation (either NIV [continuous
positive airway pressure or pressure-support ventilation
and PEEP] or invasive mechanical ventilation) for ARF
were prospectively enrolled hospital-wide, unless they met
exclusion criteria (Fig. 1). Subjects were allocated to one
of 4 groups based on age: (1) younger (18–44 y), (2)
middle-aged (45–64 y), (3) elderly (65–79 y), and (4) aged
(80 y).
Data Collection
On-site respiratory therapists filled out standardized data
forms at the time of mechanical ventilation initiation, in-
cluding subject demographics and characteristics, etiology
of ARF, time and location of initiation, and equipment and
settings used. Investigators recorded any missing informa-
tion post hoc by reviewing medical records on site and
recorded duration of use, diagnoses, complications, and
clinical outcomes.
The etiology of ARF was allocated to one of 6 sub-
groups, as described previously14: (1) acute-on-chronic lung
disease (ie, COPD and other chronic lung diseases); (2) de
novo ARF (ie, pneumonia and ARDS); (3) cardiogenic
pulmonary edema; (4) ARF associated with neurologic
diseases (including drug or alcohol overdose); (5) cardio-
pulmonary arrest; and (6) others (postextubation failure,
immunosuppressed with ARF, sepsis, shock, and other
diseases).
Outcome Variables
The primary outcome was the utilization rate of NIV as
a percentage of all ventilator starts for ARF in each age
group. The secondary outcomes were NIV success (defined
as avoidance of intubation or death during use of NIV or
the subsequent 48 h)14 and in-hospital mortality rates per
age group. Other secondary outcomes included subject
characteristics and physiologic variables, location of use,
duration of mechanical ventilation use, and length of stay
QUICK LOOK
Current knowledge
Noninvasive ventilation (NIV) represents a standard of
care in the treatment of exacerbations of COPD and
cardiogenic pulmonary edema. The use of NIV in other
causes of acute respiratory failure has met with less
success and can delay definitive treatment. NIV has
also been used successfully in patients with a do-not-
intubate status as part of palliative care.
What this paper contributes to our knowledge
In a review of an existing database, NIV was used more
frequently in subjects older than 65 y compared with
those  65, approaching 50% of ventilator starts for
acute respiratory failure. The use of NIV in these sub-
jects reflects the greater prevalence of chronic lung
disease and cardiogenic pulmonary edema in this group.
The outcome of do-not-intubate subjects was associated
with a higher mortality in both age groups.
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in hospital. Outcomes were also assessed for subjects with
do-not-intubate orders in the different age groups.
Statistical Analysis
Statistical analysis was performed using SPSS 12.0
(SPSS, Chicago, Illinois). The educational intervention did
not consider age, and given that there were no significant
differences within age groups between the before and after
surveys, we combined subjects from the before and after
groups to maximize our numbers.
Continuous variables were expressed as median with
interquartile range and compared using the Mann-Whitney
U test or Kruskal-Wallis test. The chi-square test (with the
Monte Carlo method) was used for categorical data when
appropriate. A 2-tailed P value of .05 was considered
statistically significant.
Results
NIV Utilization Rates Per Age Group
As shown in Figure 1, 1,225 cases of ARF were en-
rolled into our study. Utilization rate of NIV as a first-line
ventilator modality was 41% among all ventilator starts
and 22, 34, 49, and 47% for younger, middle-aged, el-
derly, and aged groups, respectively (P  .001).
Subject Characteristics
Compared with invasive mechanical ventilation subjects,
NIV subjects were older and more tachypneic with higher
systolic and diastolic blood pressures and higher body mass
indexes (Table 1). All NIV age groups had lower Simpli-
fied Acute Physiology Score II (SAPS II) and more often
had a do-not-intubate status than the corresponding inva-
sive mechanical ventilation age groups, as would be
expected.
Among subjects receiving NIV, the older age groups
had significantly lower body mass indexes, heart rates, and
pH values and higher PCO2 values, SAPS II, and rates of
do-not-intubate orders than the younger and middle-aged
groups (Table 1). However; after adjusting for the age
effect on SAPS II, the severity of illness was highest in the
younger group (P  .02).
NIV subjects were admitted mainly from home in all
age groups, followed by other acute care hospitals in
younger and nursing/group homes in the other age groups
(Table 2). The location of NIV initiation did not differ
within the age groups (Table 2). On the other hand, the
greatest portion of subjects with a do-not-intubate status
initiated on NIV were elderly in the ICU and aged on
regular wards (0, 10, 51, and 39% (P  .030) and 0, 14,
38, and 48% (P  .22), respectively). Additionally, irre-
spective of age, there was an increased use of NIV outside
of the ICU for do-not-intubate subjects compared with
subjects without a do-not-intubate order (68% vs 56%,
respectively, P  .03) (Table 2).
Overall, the most common etiology for ARF was neu-
rologic (mainly drug overdoses) in the younger age group,
acute-on-chronic lung disease in the elderly, and cardio-
genic pulmonary edema in the aged, together with an equal
distribution of these in the middle-aged (Fig. 2) (P .001).
Among subjects receiving NIV, pneumonia and other acute
lung diseases predominated in the younger, acute-on-
chronic lung disease in the middle-aged, and elderly and
cardiogenic pulmonary edema in the aged groups (Fig. 3)
(P  .001).
NIV Success and Mortality Rates and
Other Outcomes
Overall NIV success and mortality rates were similar
between age groups regardless of do-not-intubate status
(Table 3, P  .08 and .12, respectively). As anticipated,
overall in-hospital mortality was significantly lower for
NIV than invasive mechanical ventilation subjects (18% vs
32%, respectively, P .001), but mortality rates were similar
between the NIV and invasive mechanical ventilation groups
for younger subjects (18% vs 14%, respectively, P  .61).
Among subjects receiving NIV, aged subjects (80 y) had
significantly higher NIV success and mortality rates than the
Fig. 1. Flow chart. IMV  invasive invasive mechanical ventilation;
ETI  intubation; NIV  noninvasive ventilation; ARF  acute re-
spiratory failure.
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combined younger groups (80 y) (76% vs 66% and 25% vs
16%, P  .040 and .02, respectively).
Mean length of stay and total duration of mechanical
ventilation were similar between NIV and invasive me-
chanical ventilation groups for different age groups (data
not shown), except for total duration of mechanical ven-
tilation being significantly longer for invasive mechanical
ventilation than NIV in aged subjects (4.7 vs 2.6 d,
P  .001). Withdrawal of support rates, hospital length of
stay for NIV subjects, and duration of NIV use did not
differ between age groups (Table 3). Complications (such
as pneumonia, gastric distention, pneumothorax, and vom-
iting into mask) were similarly infrequent in the different
age groups.
Table 2. Location of Admittance From and Noninvasive Ventilation (NIV) Initiation for All NIV Subjects and NIV Subjects With Do-Not-
Intubate Order
18–44 y
(All/DNI n  28/2)
45–64 y
(All/DNI n  135/16)
65–79 y
(All/DNI n  201/37)
80 y
(All/DNI n  135/42)
Admitted from*
Home 20 (74)/2 (100) 106 (78)/10 (63) 167 (83)/27 (73) 78 (58)/16 (38)
NH/group home/AL 2 (7)/0 22 (16)/6 (37) 16 (8)/8 (22) 51 (38)/26 (62)
Other acute care hospitals 5 (19)/0 4 (3)/0 7 (4)/0 3 (2)/0
Rehabilitation centers 0/0 1 (1)/0 7 (4)/2 (5) 2 (2)/0
Other 0/0 2 (2)/0 1 (1)/0 0/0
Location of initiation†
ED 8 (29)/2 (100) 54 (40)/9 (56) 63 (31)/13 (35) 60 (44)/20 (48)
ICU 15 (53)/0 49 (37)/3 (19) 94 (47)/16 (43) 51 (38)/12 (28)
Wards 5 (18)/0 26 (19)/3 (19) 39 (19)/8 (22) 21 (16)/10 (24)
Other 0/0 6 (4)/1 (6) 5 (3)/0 3 (2)/0
Categorical variables are provided as number of subjects and percentage of subjects within that age group in parentheses for all noninvasive ventilation subjects and subjects with a do-not-intubate
order, respectively.
* P  .001; data were available for 27, 135, 198, and 134 subjects for each age group, respectively.
† P  .26.
DNI  do-not-intubate
NH  nursing home
AL  assisted living
ED  emergency department
Fig. 2. Number of ventilator starts (including both noninvasive ventilation [NIV] and invasive mechanical ventilation subjects) based on age
and etiology of ARF. Numbers above bars are NIV utilization rates (ie, NIV starts/total ventilator starts for acute respiratory failure).
ARF  acute respiratory failure.
NIV FOR ACUTE RESPIRATORY FAILURE IN DIFFERENT AGE GROUPS
40 RESPIRATORY CARE • JANUARY 2016 VOL 61 NO 1
Discussion
In this prospective cohort study, we found that NIV
utilization for ARF as a percentage of all ventilator starts
was highest for subjects 65 y old and lowest for subjects
18–44 y old, which is probably explained by the greater
prevalence of chronic lung or heart disorders in the older
and neurologic/toxic conditions (mainly drug and alcohol
overdose) in the younger age groups. Additionally, do-not-
intubate status was observed more frequently with aging,
also contributing to greater use of NIV in the elderly and
aged. NIV success and in-hospital mortality rates were
similar in the different age groups.
A number of previous studies support the use of NIV in
older age groups.4-7,15 Benhamou et al15 reported more
frequent use of NIV in elderly subjects with ARF admitted
to an ICU (64%) than in younger subjects (47%), with
higher mortality in the elderly group (21% vs 9%, respec-
tively) reflecting outcomes in the general ICU population.
In a randomized, controlled trial of elderly subjects with
hypercapnic ARF admitted to a respiratory care unit, NIV
decreased the rate of meeting intubation criteria (7.3 vs
63.4%, P .001) and mortality (odds ratio .40, P .05)
compared with standard medical treatment.7
Consistent with the above results, our study shows greater
utilization of NIV with advancing age. Stefan et al2 also
reported increasing use of NIV with age for 1,364,624
medical subjects hospitalized with an ARF diagnosis (12,
21, 28, and 34% in subjects age 18–44, 45–64, 65–84,
and 85 y old, respectively). The lower rates of NIV use
compared with our study could be due to their reliance on
the International Classification of Diseases, Ninth Revi-
sion, Clinical Modification (ICD9-CM) coding16; differ-
ences in prevalence of etiologies of ARF (pneumonia being
the most common diagnosis); or different practices be-
tween our hospitals and those in the sample of Stefan
et al.2 In addition, they observed that older subjects re-
ceived less invasive mechanical ventilation and less ex-
pensive care overall, consistent with earlier studies3,17,18
and with the idea that intensity of care decreases with
aging as more patients and their proxies choose to limit
treatment. In a 2-y prospective cohort study on subjects
with ARF admitted to a medical ICU, Schortgen et al6 also
reported NIV use in 60% of elderly subjects (80 y old)
requiring ventilator support compared with only 32% of
younger subjects. Our NIV utilization rate in aged subjects
was 47%, but this lower rate was in a population with a
lower prevalence of do-not-intubate status than in the study
by Schortgen et al6 (31% vs 40%).
With regard to subject characteristics, our older NIV
subjects had lower body mass indexes and heart rates with
more frequent acidosis, hypercapnia, and do-not-intubate
statuses than younger subjects, similar to Schortgen et al.6
These differences from younger age groups most likely
reflect the greater prevalence of acute-on-chronic lung dis-
ease and other chronic illnesses among older patients. Also
in our study, the severity of illness increased with age, but
after adjustment for age, SAPS II scores were actually
higher in the younger age group, due to their greater prev-
alence of neurologic/toxic and de novo ARF. Reflecting
the greater burden of chronic illness, aged subjects were
also more likely to be admitted from chronic care facilities
compared with other groups.
Contrary to our expectations, age alone did not deter-
mine the location of care in our study, but subjects with a
do-not-intubate status were more often treated outside of
the ICU than those without a do-not-intubate order. In a
previous survey, subjects with cancer and their caretakers
considered the ICU “a bad place to die.”19 Our study found
that slightly more than a quarter of elderly do-not-intubate
subjects using NIV were treated in the ICU; considerations
like need for nursing care and monitoring, bed availability,
and patient and/or family preference may override ethical
considerations so that a significant minority of such pa-
tients still receive ICU care. On the other hand, 10 of 21
(48%) aged subjects treated on regular wards had a
do-not-intubate status as opposed to 11 of 70 (16%) of
those  80 y (P  .001).
Palliative use of NIV in patients with a do-not-intubate
order or when endotracheal intubation is deemed inappro-
priate has become increasingly common.20,21 In our study,
a do-not-intubate status imparted a worse prognosis among
subjects treated with NIV compared with those without
one, undoubtedly related to a higher prevalence of diseases
with worse prognoses. However, there was no significant
impact of age on outcomes of NIV subjects with a do-not-
intubate status.
Prior studies have reported conflicting results on the
effect of age and the presence of a do-not-intubate order
on NIV failure rate. Scarpazza et al4 found that older age
Fig. 3. Distribution of causes of acute respiratory failure (ARF) in
subjects using noninvasive ventilation (NIV) according to age
groups.
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was associated with a higher NIV failure rate. In contrast,
in a recent multi-center French database study including
3,163 subjects with ARF requiring ventilator support (but
excluding do-not-intubate patients) younger age was found
to be one of the independent risk factors for NIV failure
(P  .001).22 In the study by Schortgen et al,6 NIV failure
rates were similar across age groups (40% vs 42% in sub-
jects 80 y and 80 y, respectively), and mortality rates
were shown to be higher in the older subjects (25% vs
40%, P  .01). Our study found no association between
the different age groups with regard to success or mortality
rates. This may reflect the counterbalancing effects of a
higher rate of NIV failure and mortality associated with de
novo respiratory failure in the younger age group and the
higher rate of withdrawal of support in the aged. On the
other hand, when we combined all subjects younger than
80 y and compared them with subjects  80 y, the aged
had higher NIV success and mortality rates, probably due
to the higher prevalence of chronic disorders and do-not-
intubate orders, respectively.
Limitations of our study include its observational design
and lack of controls, precluding conclusions about the ef-
fectiveness of NIV in different age groups. In addition, the
data were accrued from selected hospitals in a region of
the United States and may not be generalizable to other
centers elsewhere. Furthermore, although the number of
subjects enrolled is higher than in most of the prior epi-
demiologic studies, we are limited by small numbers of
subjects in some of our subgroups (especially the younger).
Our study also has important strengths, including our
acquisition of data by prospective identification of sub-
jects and on-site data gathering that offers greater reliabil-
ity compared with off-site survey studies. We have also
selected a group of hospitals representing a mix of aca-
demic and community settings, providing a real-life snap-
shot of actual NIV use.
Conclusions
We conclude that NIV is used more frequently in sub-
jects older than 65 y than in younger subjects, approaching
50% of ventilator starts for ARF, reflecting the higher
prevalence of acute-on-chronic lung disease and cardio-
genic pulmonary edema as causes of ARF in the older age
groups. NIV is used least often in adults 45 y, reflecting
the higher prevalence of neurologic and de novo causes of
ARF than in the older age groups, etiologies for which
NIV is used infrequently. NIV success and in-hospital
mortality rates are similar between age groups. Having a
do-not-intubate status is associated with a higher mortality
in NIV subjects than in those without one, but age does not
affect outcome in do-not-intubate subjects treated with NIV.
These data support the routine use of NIV to treat elderly
and aged patients with ARF when they have appropriate
diagnoses, with the expectation of achieving outcomes at
least as good as or even better than those in younger
patients.
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(All/DNI n  499/97) P
Success rates, %
All NIV subjects 54 65 68 76 69 .08
NIV subjects with DNI 50 56 68 79 70 .27
NIV subjects without DNI 54 66 68 74 68 .25
Mortality rates, %
All NIV subjects 18 13 17 24 18 .11
NIV subjects with DNI 50 38 35 33 35 .98
NIV subjects without DNI 15 10 13 20 14 .17
Withdrawal of support, %
All NIV subjects 14 10 10 19 13 .12
NIV subjects with DNI 50 38 16 26 25 .29
Hospital LOS, d 11 (6–22) 7 (4–14) 7 (4–13) 7 (4–11) 7 (4–13) .02
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LOS  length of stay
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